Artiva Biotherapeutics Announces FDA Clearance of IND for AlloNK® Cell Therapy Candidate in Combination with Rituximab in Lupus Nephritis Read More Aug 16, 2023
Attovia Therapeutics Launches with $60 Million Series A Financing to Unlock Potential of Novel Biparatopic Nanobody Platform Read More Jun 20, 2023
Abdera Therapeutics Debuts With $142 Million in Financing to Engineer and Advance Best-in-Class Antibody-Based Radiopharmaceuticals for Cancer Read More Apr 20, 2023
Abdera skyrockets out of stealth with $142M as radiopharmaceutical ambitions take flight Read More Apr 20, 2023
Entact Bio’s CEO is leading the company out of stealth and into a new age of protein enhancement Read More Feb 27, 2023